According to the recent research report titled ‘Health Economics & Outcomes Research (HEOR) Services Market Size By Service, By Service Provider, By End-user , Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report, global health economics & outcomes research (HEOR) services market is anticipated to register robust growth during 2020-2026.
 

Growing outsourcing of research & development activities, increasing spending on research & development worldwide, inclination of pharma & biotech firms on new drug development, and surging number of clinical trials are the key factors driving the growth global health economics & outcomes research (HEOR) services market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2484000/
 

On the downside, lack of skilled healthcare professionals in underdeveloped and developing countries is likely to hamper the remuneration scale of the industry over the study period.
 

Based on service type, market access solutions & reimbursement segment is predicted to record a 13.4% CAGR through 2026, owing to its major role in governing the market access strategy during the entire product lifecycle and help in excellent decision-making resources.
 

Speaking of service provider, contract research organization (CRO) segment of global health economics & outcomes research (HEOR) services market was worth USD 500 million in 2019 and is expected to register a decent growth in the ensuing years, on account of the support it offers to pharmaceutical and biotechnology sectors by outsourcing pharmaceutical research services for both medical devices and drugs.
 

Moving on to end-user scope, healthcare providers segment is likely to record a 12.7% CAGR over the estimated timeframe, credible to HEOR services which support healthcare providers in analyzing and assessing the data of the patient and consequently, aid in decision-making.
 

From the regional perspective, Asia Pacific held 15.5% shares of global health economics & outcomes research (HEOR) services industry in 2019 and is reckoned to accrue notable gains through 2026, attributable to rising cognizance among people regarding HEORs services and cost advantage offered by it.
 

Meanwhile, Latin America health economics & outcomes research (HEOR) services industry is anticipated to record a 13.1% CAGR over the forecast timespan, on account of strong presence of CROs in the region and well-established regulatory environment.
 

As per the report, MEA health economics & outcomes research (HEOR) services market valuation is expected to reach USD 20 million by 2026, attributable to rising investment in R&D activities. Introduction of the potential new products which are in the development state are also contributing to the regional market outlook.
 

Major players influencing global health economics & outcomes research (HEOR) services market dynamics are TCD, Syneos Health Inc., RTI Health Solutions, Pharmaceutical Product Development, LLC. (PPD), Pharma Lex GmbH, Optum, Inc., Medlior Health Outcomes Research Ltd., McKesson Corporation, IQVIA, Cardinal Health Inc., Avalon Health Economics LLC, and Axtria.